Hougton R.,Quotient Bioresearch |
Gouty D.,Intertek |
Allinson J.,ICON Development Solutions |
Green R.,Quotient Bioresearch |
And 25 more authors.
The 5th GCC in Barcelona (Spain) and 6th GCC in San Antonio (TX, USA) events provided a unique opportunity for CRO leaders to openly share opinions and perspectives, and to agree upon recommendations on biomarker bioanalytical method validation. © 2012 Future Science Ltd. Source
Sangster T.,Charles River Associates |
Maltas J.,BASi |
Struwe P.,Celerion |
Hillier J.,Gen-Probe |
And 27 more authors.
The 5th Global CRO Council for Bioanalysis (GCC) meeting, held in Barcelona, Spain, in November 2011, provided a unique opportunity for CRO leaders to openly share opinions, perspectives and to agree on bioanalytical recommendations on incurred sample reproducibility in multi-analyte assays, regulation of quality assurance/bioanalytical consultants and regulatory requirements for GCP. © 2012 Future Science Ltd. Source
Lowes S.,Quintiles |
Boterman M.,ABL |
Doig M.,ABS Laboratories |
Breda M.,Accelera |
And 86 more authors.
An open letter written by the Global CRO Council for Bioanalysis (GCC) describing the GCC survey results on stability data from co-administered and co-formulated drugs was sent to multiple regulatory authorities on 14 December 2011. This letter and further discussions at different GCC meetings led to subsequent recommendations on this topic of widespread interest within the bioanalytical community over the past 2 years. © 2012 Future Science Ltd. Source